The results from a recent report on 33 MYB/MYBL1-altered glioma cases show that a substantial proportion of the cases (at least 13/33) exhibited a rearrangement of the MYB or MYBL1 gene in the absence of a recognizable fusion partner [8]. This evidence concerns the gene MYBL1 and central nervous system cancer.